Understanding the Relationship Between Infliximab Levels to Clinical Response of Remicade in Crohn's Disease

Summary

The purpose of this study is to improve the investigators understanding of the relationship between Crohn's disease and blood levels of the drug infliximab (Remicade). The investigators want to determine whether measuring drug levels can be helpful in understanding how patients respond to this treatment.

Timeline

Start

2011-12

Primary completion

2013-12

Completion

2013-12

Drugs

Indications